CTSO Stock Summary and Trading Ideas (Cytosorbents | NASDAQ:CTSO)

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Cytosorbents trades on the NASDAQ stock market under the symbol CTSO.

As of March 3, 2025, CTSO stock price climbed to $1.08 with 36,553 million shares trading.

CTSO has a beta of 0.52, meaning it tends to be less sensitive to market movements. CTSO has a correlation of 0.01 to the broad based SPY ETF.

CTSO has a market cap of $65.80 million. This is considered a Micro Cap stock.

Last quarter Cytosorbents reported $9 million in Revenue and -$.04 earnings per share. This fell short of revenue expectation by $-790,000 and exceeded earnings estimates by $.02.

In the last 3 years, CTSO traded as high as $4.59 and as low as $.70.

The top ETF exchange traded funds that CTSO belongs to (by Net Assets): VTI, VXF, MSSM.

CTSO has underperformed the market in the last year with a price return of +11.3% while the SPY ETF gained +17.9%. However, in the short term, CTSO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +18.7% vs -1.2% return in SPY. But in the last 2 weeks, CTSO shares have been beat by the market, returning -16.9% compared to an SPY return of -3.2%.

CTSO support price is $.99 and resistance is $1.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTSO shares will trade within this expected range on the day.